Table 1.
Demographic and clinical characteristics
| Total (n = 199) | |
|---|---|
| Age (years); mean (SD) | 43.9 (10.5) |
| Gender (female); n (%) | 121 (60.8%) |
| Educational level; n (%) | |
| -Primary | 32 (16.1%) |
| -Secondary | 88 (44.2%) |
| -University/Postgraduate studies | 79 (39.7%) |
| Type of MS; n (%) | |
| -RRMS | 172 (86.4%) |
| -PPMS | 27 (13.6%) |
| Time since diagnosis (years); mean (SD) | 9.6 (7.2) |
| Number of relapses in the last 2 years; mean (SD) | 0.6 (0.9) |
| Time since last relapse (months); mean (SD) | 53.9 (56.1) |
| Patients on DMT; n (%) | 160 (80.4%) |
| EDSS score; median (IRQ) | 2.0 (1.0, 3.5) |
| MSWDQ-23 total score; median (IRQ) | 31.5 (15.2, 50.0) |
DMT Disease-modifying therapies, EDSS Expanded Disability Status Scale, IRQ Interquartile range, MS Multiple sclerosis, MSWDQ-23 23-item Multiple Sclerosis Working Difficulties, PPMS Primary progressive multiple sclerosis, RRMS Relapsing-remitting multiple sclerosis, SD Standard deviation